All SK Group affiliates will achieve net zero carbon emissions ahead of its 2050 goal, SK inc. Chairman Chey Tae-won said at an executive-level meeting on Tuesday.
SK Bioscience, a contract manufacturer of Covid-19 vaccines developed by AstraZeneca and Novavax, will spend 150 billion won ($132 million) by 2024 to ramp up the production capacity of its facility in Andong, North Gyeongsang.
According to the Korea T Commerce Association (Kotca), T-commerce operators sold around 5.4 trillion won ($4.8 billion) worth of goods and services in 2020. This is a fivefold increase from 2016’s 997.7 billion won.
SK Biopharmaceuticals' epilepsy drug Cenobamate has begun sales in Europe, launching initially in Germany under the name Ontozry in early June.
Pay rises continue at Korea's big companies and IT firms.
Yposkesi, SK Pharmteco’s bio subsidiary in France, will invest 58 million euros ($70 million) to build a second factory in Genopole, France.
SK Telecom will be dividing into two companies, one focused on core businesses and the other on investments and new areas.
The heads of four Korean business groups met Thursday to form a committee dedicated to investment and business opportunities in hydrogen.
A total of 229 battery makers including SK Innovation, LG Energy Solution and Samsung SDI participated the battery exhibition, which will run until June 11.
The Export-Import Bank of Korea is extending a $500 million green loan to SK Innovation for its second electric vehicle (EV) battery plant in Hungary.